scPharmaceuticals (FRA:2SX) Marketable Securities : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is scPharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. scPharmaceuticals's Marketable Securities for the quarter that ended in Sep. 2024 was €0.00 Mil.

scPharmaceuticals's annual Marketable Securities increased from Dec. 2021 (€0.89 Mil) to Dec. 2022 (€44.49 Mil) but then declined from Dec. 2022 (€44.49 Mil) to Dec. 2023 (€26.78 Mil).

scPharmaceuticals Marketable Securities Historical Data

The historical data trend for scPharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

scPharmaceuticals Marketable Securities Chart

scPharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

27.35

0.89

44.49

26.78

scPharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															51.68	26.78	-	-	-

scPharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

scPharmaceuticals (FRA:2SX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

scPharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of scPharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

scPharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » scPharmaceuticals Inc (FRA:2SX) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

SCPH:USA

Address

25 Mall Road, Suite 203, Burlington, MA, USA, 01803

Website

https://www.scpharmaceuticals.com

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

scPharmaceuticals Headlines

No Headlines